D&O Ongoing Disclosure – Malcolm Tubb

Ongoing Disclosure Notice Disclosure of Directors and Senior Managers Relevant Interests Sections 297(2) and 298(2), Financial Markets Conduct Act 2013 To NZX Limited; and Name of listed issuer: AFT Pharmaceuticals Limited (AFT) Date this disclosure made: 14-Apr-21 Date of last disclosure: 24-Apr-20 Director or senior manager giving disclosure Full name(s): Malcolm Tubby Name of listed issuer: AFT Pharmaceuticals Limited (AFT) Name of related body corporate (if applicable): Not applicable Position held in listed issuer: Chief Financial Officer Summary of acquisition or disposal of relevant interest (excluding specified derivatives) Class of affected quoted financial products: 1. Unlisted options to acquire Fully-Paid Ordinary Shares in AFT (Ordinary Shares) 2. Ordinary Shares in AFT Nature of the affected relevant interest(s): Registered holder and beneficial interest For that relevant interest- Number held in class before acquisition or disposal: 1. 50,000 unlisted options 2. 15,100 Ordinary Shares Number held in class after acquisition or disposal: 1. 0 unlisted options 2. 65,100 ordinary shares Current registered holder(s): Malcolm Tubby Registered holder(s) once transfers are registered: Malcolm Tubby Details of transactions giving rise to acquisition or disposal Total number of transactions to which notice relates: 1 Details of transactions requiring disclosure- Date of transaction: 13-Apr-21 Nature of transaction: Exercise of 50,000 unlisted options and issue of 50,000 Ordinary Shares pursuant to AFT Share Option Plan Name of any other party or parties to the transaction (if known): The consideration, expressed in New Zealand dollars, paid or received for the acquisition or disposal. If the consideration was not in cash and cannot be readily by converted into a cash value, describe the consideration: Exercise price of NZ$2.80 per share / $140,000.00 Number of financial products to which the transaction related: 50,000 If the issuer has a financial products trading policy that prohibits directors or senior managers from trading during any period without written clearance (a closed period) include the following details-- Whether relevant interests were acquired or disposed of during a closed period: Not applicable Whether prior written clearance was provided to allow the acquisition or disposal to proceed during the closed period: Not applicable Date of the prior written clearance (if any): Not applicable Summary of other relevant interests after acquisition or disposal: Class of quoted financial products: Ordinary Shares Nature of relevant interest: 1. Joint registered holder and beneficial owner as trustee of the Jembag Trust 2. Power to control the exercise of the right to vote or dispose of financial product For that relevant interest,- Number held in class: 1. 75,218 2. 3,574 Current registered holder(s): 1. Barbara Tubby, Colin Tubby & Malcolm Tubby as trustees of the Jembag Trust 2. Barbara Tubby, Alison Tubby, Juliette Tubby, Emily Tubby, George Tubby For a derivative relevant interest,- Type of derivative: Not applicable Details of derivative,- The notional value of the derivative (if any) or the notional amount of underlying financial products (if any): Not applicable A statement as to whether the derivative is cash settled or physically settled: Not applicable Maturity date of the derivative (if any): Not applicable Expiry date of the derivative (if any): Not applicable The price's specified terms (if any): Not applicable Any other details needed to understand how the amount of the consideration payable under the derivative or the value of the derivative is affected by the value of the underlying financial products: Not applicable For that derivative relevant interest,- Parties to the derivative: Not applicable If the director or senior manager is not a party to the derivative, the nature of the relevant interest in the derivative: Not applicable Certification I certify that, to the best of my knowledge and belief, the information contained in this disclosure is correct and that I am duly authorised to make this disclosure by all persons for whom it is made. Signature of director or officer: Date of signature: 14-Apr-21 End CA:00370602 For:AFT Type:SHINTR Time:2021-04-14 09:11:31